EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 276 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $5,000 | -16.7% | 90 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | -93.5% | 90 | -91.0% | 0.00% | -100.0% |
Q1 2021 | $92,000 | 0.0% | 998 | -3.1% | 0.01% | -14.3% |
Q4 2020 | $92,000 | -4.2% | 1,030 | +10.0% | 0.01% | -12.5% |
Q3 2020 | $96,000 | +4.3% | 936 | -19.9% | 0.01% | 0.0% |
Q2 2020 | $92,000 | +21.1% | 1,168 | -10.8% | 0.01% | 0.0% |
Q1 2020 | $76,000 | -5.0% | 1,310 | -12.2% | 0.01% | +14.3% |
Q4 2019 | $80,000 | -20.0% | 1,492 | -22.4% | 0.01% | -30.0% |
Q3 2019 | $100,000 | -28.1% | 1,922 | -33.4% | 0.01% | -28.6% |
Q2 2019 | $139,000 | -2.1% | 2,884 | +2.6% | 0.01% | -6.7% |
Q1 2019 | $142,000 | -2.1% | 2,812 | +15.0% | 0.02% | -11.8% |
Q4 2018 | $145,000 | +237.2% | 2,446 | +272.9% | 0.02% | +240.0% |
Q3 2018 | $43,000 | +30.3% | 656 | 0.0% | 0.01% | +25.0% |
Q2 2018 | $33,000 | -8.3% | 656 | -4.1% | 0.00% | 0.0% |
Q1 2018 | $36,000 | +3500.0% | 684 | +3320.0% | 0.00% | – |
Q4 2017 | $1,000 | – | 20 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |